Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
2.190
0.00 (0.00%)
Sep 24, 2026, 9:30 AM EDT - Market open
Serina Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Serina Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $9.50. The average 1-year stock price forecast is 333.79% higher than the current stock price, while the lowest is $8.00 (+265.30%) and the highest is $11 (+402.28%).
Price Target: $9.50 (+333.79%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Serina Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Mar '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $8 | Buy | Maintains | $8 | +265.30% | Sep 11, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $11 | Buy | Reiterates | $11 | +402.28% | Aug 18, 2026 |
Financial Forecast
Revenue This Year
n/a
from 130.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-1.41
EPS Next Year
-1.05
from -1.41
EPS and Forward PE are based on non-GAAP adjusted numbers.